ADRA2A polymorphism and smoking in a Turkish population

Abstract

Adrenoceptors (ARs) consist of nine subtypes, which are involved in a wide spectrum of physiological functions and are the site of action for a considerable percentage of currently prescribed therapeutics. All AR subtypes (except α_1D) can be polymorphic because of the genetic variations in the coding and non-coding regions. Sixteen sequence variations were identified in α-adrenergic 2A (ADRA2A) gene. Among them, ADRA2A C1291G polymorphism is one of the most important polymorphisms, which plays a major role in regulating neurotransmitter release, blood pressure, lipolysis, insulin secretion, and platelet aggregation. A C–G transversion results in an MspI restriction fragment length polymorphism located at 1291 bp upstream of the origin of transcription. Because Medline search showed no study showing the allelic frequencies, and no information is available on inter-individual variability of ADRA2A C1291G polymorphism in Turkish population, we genotyped 203 healthy Turkish subjects. Because of large genetic variation of the polymorphism, we aimed to find out the distribution of C1291G polymorphism in Turkish population. Furthermore, we evaluated the possible association between the C1291G polymorphism in the ADRA2A receptor gene and smoking. The frequencies for the 1291C and 1291G alleles were 64% and 36%, respectively. The genotype frequencies for C1291C, C1291G, and G1291G were 35.5%, 57.6%, and 6.9%, respectively, in Turkish population. The allelic frequencies (1291C and 1291G) and G1291G homozygous variant genotype were similar to those reported in different Caucasian populations; however, C1291C and C1291G genotypes were different. We also observed that the frequency of the G allele was slightly higher in smoker subjects and lower among controls. The ADRA2A G allele may play a role in the predisposition to smoking. There is a need for expanding genotype and haplotype studies because of its importance in various physiological disorders and to confirm the association of this polymorphism with smoking.

Keywords

ADRA2A gene C1291G genetic polymorphism ethnic differences race differences smoking habit Turkish population

Get full access to this article

View all access options for this article.

References

Cami J Farre M (2003) Drug addiction. N Engl J Med 349: 975–986.

Clark DA Mata I Kerwin RW Munro J Arranz MJ (2007) No association between ADRA2A polymorphisms and schizophrenia. Am J Med Genet B Neuropsychiatr Genet 144: 341–343.

Devedjian C Pujol A Cayla C George M Casellas A Paris H (2000) Transgenic mice overexpressing alpha2A-adrenoceptors in pancreatic beta-cells show altered regulation of glucose homeostasis. Diabetologia 43: 899–906.

Eason MG Liggett SB (1993) Human alpha 2-adrenergic receptor subtype distribution: widespread and subtype-selective expression of alpha 2C10, alpha 2C4, and alpha 2C2 mRNA in multiple tissues. Mol Pharmacol 44: 70–75.

Garenc C Perusse L Chagnon YC Rankinen T Gagnon J Borecki IB (2002) The alpha2-adrenergic receptor gene and body fat content and distribution: the HERITAGE Family Study. Mol Med 8: 88–94.

Hein L Altman JD Kobilka BK (1999) Two functionally distinct alpha2-adrenergic receptors regulate sympathetic neurotransmission. Nature 402: 181–184.

Karahalil B Kocabas NA (2005) hOGG1 Ser326Cys genetic polymorphism in a Turkish population. Arch Toxicol 79: 377–380.

Lafontan M Berlan M (1995) Fat cell alpha 2-adrenoceptors: the regulation of fat cell function and lipolysis. Endocr Rev 16: 716–738.

Lima JJ Feng H Duckworth L Wang J Sylvester JE Kissoon N (2007) Association analyses of adrenergic receptor polymorphisms with obesity and metabolic alterations. Metab Clin Exp 56: 757–765.

10.

Matsunaga T Yasuda K Adachi T Gu N Yamamura T Moritani T (2007) Alpha-adrenoceptor gene variant and autonomic nervous system function in a young healthy Japanese population. J Hum Genet 52: 28–37.

11.

Ohara K Nagai M Tani K Tsukamoto T Suzuki Y Ohara K (1998) Polymorphism in the promoter region of the alpha 2A adrenergic receptor gene and mood disorders. Neuroreport 9: 1291–1294.

12.

Park L Nigg JT Waldman ID Nummy KA Huang-Pollock C Rappley M (2005) Association and linkage of a-2A adrenergic receptor gene polymorphisms with childhood ADHD. Mol Psychiatry 10: 572–580.

13.

Picciotto MR Corrigall WA (2002) Neuronal systems underlying behaviors related to nicotine addiction: neural circuits and molecular genetics. J Neurosci 22: 3338–3341.

14.

Polanczyk G Zeni C Genro JP Guimaraes AP Roman T Hutz MH (2007) Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 64: 218–224.

15.

Prestes AP Marques FZC Hutz MH Roman T Bau CHD (2007) Tobacco smoking and the ADRA2A C-1291G polymorphism. J Neural Transm 114: 1503–1506.

16.

Roman T Schmitz M Polanczyk GV Eizirik M Rohde LA Hutz MH (2003) Is the alpha-2A adrenergic receptor gene (ADRA2A) associated with attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 120: 116–120.

17.

Rosmond R Bouchard C Bjorntorp P (2002) A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels. J Intern Med 251: 252–257.

18.

Tsai SJ Wang YC Hong CJ (2001) Allelic variants of the α1a adrenoceptor and the promoter region of the α2a adrenoceptor and temperament factors. Am J Med Genet 105: 96–98.

19.

Wang B Wang Y Rulun Z Li J Qian Q Yang L (2006) Possible association of the alpha-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet 141B: 130–134.

20.

Wang YC Bai YM Chen JY Lin CC Lai LC Liou YJ (2005) Polymorphism of the adrenergic receptor alpha 2a -1291 C>G genetic variation and clozapine-induced weight gain. J Neural Transm 112: 1463–1468.